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Abstract
Tuberculosis remains a global pandemic and drives lung matrix destruction to transmit.
Whilst pathways driving inflammatory responses in macrophages have been relatively well
described, negative regulatory pathways are less well defined. We hypothesised that
Mycobacterium tuberculosis (Mtb) specifically targets negative regulatory pathways to aug-
ment immunopathology. Inhibition of signalling through the PI3K/AKT/mTORC1 pathway
increased matrix metalloproteinase-1 (MMP-1) gene expression and secretion, a collage-
nase central to TB pathogenesis, and multiple pro-inflammatory cytokines. In patients with
confirmed pulmonary TB, PI3Kδ expression was absent within granulomas. Furthermore,
Mtb infection suppressed PI3Kδ gene expression in macrophages. Interestingly, inhibition
of the MNK pathway, downstream of pro-inflammatory p38 and ERK MAPKs, also increased
MMP-1 secretion, whilst suppressing secretion of TH1 cytokines. Cross-talk between the
PI3K and MNK pathways was demonstrated at the level of eIF4E phosphorylation. Mtb glob-
ally suppressed the MMP-inhibitory pathways in macrophages, reducing levels of mRNAs
encoding PI3Kδ, mTORC-1 and MNK-1 via upregulation of miRNAs. Therefore, Mtb dis-
rupts negative regulatory pathways at multiple levels in macrophages to drive a tissue-
destructive phenotype that facilitates transmission.
Author summary
The mechanisms whereby Mycobacterium tuberculosis (Mtb) evades host immunity are
well described, but Mtb must also engage the host immune response to drive tissue
destruction, cavitation and transmission as part of its life cycle. We identify negative regu-
latory pathways that suppress pathogenic matrix metalloproteinase-1 expression in
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primary human macrophages, including a previously unidentified role of the MAP
kinase-interacting kinase (MNK) pathway in inhibiting protease secretion. Furthermore,
these pathways are suppressed in granulomas of patients with culture-proven pulmonary
tuberculosis and in infected macrophages in vitro. Stability of mRNA encoding negative
regulatory molecules is reduced, and Mtb upregulates multiple microRNAs predicted to
target their 3’UTR. Together, these findings demonstrate that Mtb skews the macrophage
phenotype towards tissue destruction by disrupting negative regulatory pathways.
Introduction
Tuberculosis (TB) is a global pandemic, killing more than any other infectious disease [1], and
ongoing transmission in high incidence settings impedes control measures [2]. Mycobacterium
tuberculosis (Mtb), the causative organism, must cause lung destruction to create highly infec-
tious individuals with pulmonary cavities who drive the pandemic [3]. Cavitation results from
tissue-destructive matrix metalloproteinases (MMPs) [4], in particular MMP-1 from macro-
phages [5–7]. The signalling pathways driving MMP-1 expression have been described [5, 8],
but relatively little is known about regulatory pathways that limit immunopathology in tuber-
culosis [9].
Pro-inflammatory signalling in LPS-stimulated dendritic cells is negatively regulated by the
phosphoinositol-3 kinase (PI3K) signalling pathway, which inhibits IL-12 secretion and TLR
signalling [10, 11]. Intracellular signalling is highly complex, with cross-talk between cascades
such as the mitogen-activated protein kinase (MAPK), PI3K and MAP kinase-interacting
kinase (MNK) pathways [12]. MNKs (MNK1/2) are protein kinases which phosphorylate the
translation initiation factor eIF4E and are therefore thought to regulate mRNA translation
[13], but have not previously been studied in TB. The precise role of MNK-mediated eIF4E
phosphorylation is unclear, but is considered to differentially affect the translation of multiple
mRNAs [12–14]. Expression of these intracellular signalling molecules can be regulated by
microRNAs [15], and Mtb infection of macrophages can modulate this microRNA profile
[16–18].
We hypothesised that negative regulatory pathways in macrophages limit excessive immu-
nopathology in TB, and that the pathogen specifically targets them to exacerbate tissue
destruction and consequently transmission. In the present study, we have identified for the
first time regulatory pathways which limit MMP-1 production in human macrophages, includ-
ing PI3K, AKT and mTORC1, and show that PI3K expression is reduced in pulmonary granu-
lomas of patients with TB. Intriguingly, MNK inhibition also increases MMP-1 secretion by as
yet an undescribed signalling pathway. Furthermore, Mtb infection suppresses mRNA levels
of multiple regulatory pathways in macrophages via augmenting expression of several key
micro-RNAs (miRNA). Therefore, the pathogen skews the macrophage response to promote
tissue destruction.
Results
The PI3K pathway negatively regulates MMP-1 expression in primary
human macrophages
As previously demonstrated, Mtb infection of primary human macrophages significantly
increased MMP-1 secretion and expression (Fig 1A and 1B). However, global inhibition of
PI3K signalling with the pan-PI3K inhibitor LY294002 further augmented Mtb-induced
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Fig 1. PI3K inhibition augments Mtb-driven macrophage MMP-1 secretion. A. Global inhibition of the PI3K kinase pathway with
LY294002 significantly increases macrophage MMP-1 secretion at 72h. B. PI3K inhibition increases macrophage MMP-1 gene expression
at 24 h. C. Targeted inhibition of PI3Kδwith IC87114 similarly increases MMP-1 secretion at 72h. D. Increased secretion with IC87114 is
secondary to increased mRNA accumulation at 24h. E. Mtb infection increases AKT phosphorylation from 30 minutes, peaking at 60
minutes and declining after 4 h. AKT phosphorylation is completely inhibited by LY294002 at 30 minutes and 4 h. F. Targeted inhibition of
PI3K / PDK1 with NVP-BAG956 also increases MMP-1 secretion at 72h. Data show mean and standard deviation of experiments
performed in triplicate and are representative of experiments performed on a minimum of three occasions. P values are Student’s t-test.
https://doi.org/10.1371/journal.ppat.1006367.g001
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MMP-1 secretion (Fig 1A) and gene expression (Fig 1B). The PI3K pathway has multiple sub-
units, and we studied the PI3Kδ subunit which is specifically expressed in cells derived from
the blood by specific inhibition with IC87114 (PI3Kδ, PI3Kγ and PI3Kβ = IC50 0.5, 29 and
75μM, respectively). Consistent with the global inhibition, PI3Kδ inhibition significantly upre-
gulated MMP-1 secretion (Fig 1C) and MMP-1 gene expression (Fig 1D). LY294002 did not
suppress expression of PIK3CD, the gene encoding PI3Kδ, in macrophages after 24h of incuba-
tion (S1 Fig). We subsequently evaluated AKT phosphorylation, immediately downstream of
PI3K within the signalling cascade. Mtb infection induced AKT phosphorylation at Ser 473
within 30 minutes, peaking at 60 minutes and was still evident at 120mins. This downstream
signalling was completely inhibited by LY294002 (Fig 1E and S2 Fig). To address the question
of potential off-target effects of the inhibitors, we evaluated an additional PI3K/PDK1 inhibi-
tor, NVP-BAG956, and again demonstrated increased MMP-1 secretion after inhibition (Fig
1F). To investigate whether MMP-1 upregulation was augmented by intercellular networks,
we stimulated macrophages with conditioned media from Mtb-infected monocytes. MMP-1
secretion was increased after stimulation with media from infected macrophages, demonstrat-
ing that intercellular networks can augment MMP-1 driven by Mtb infection (S3 Fig).
PI3K inhibition globally modulates the inflammatory secretome of
macrophages
To determine whether the PI3K regulation of MMP-1 was specific or part of a more wide-
spread phenomenon, we profiled secretion of MMPs, cytokines, chemokines and growth
factors by uninfected and infected macrophages using a Luminex array. Mtb infection upregu-
lated numerous mediators, and inhibition of PI3K signalling had an additive effect, causing
further upregulation of secretion of multiple MMPs, TH1 and TH2 cytokines, chemokines and
growth factors (Fig 2). In the context of PI3K pathway inhibition, the majority of pro-inflam-
matory mediators were upregulated.
PI3Kδ expression is suppressed in TB lesions and in infected
macrophages
Next, we investigated PI3Kδ signalling in lung lesions of patients with confirmed pulmonary
TB. Initially, we performed immunohistochemistry for phosphorylated PI3K to determine
activation in vivo, but were unable to demonstrate immunoreactivity. Therefore, we ana-
lyzed total PI3Kδ, but again were unable to detect expression. In normal lung tissue, alveolar
macrophages expressed both CD68 and PI3Kδ (Fig 3A and 3B). Within tuberculosis granu-
lomas, CD68 expression is widespread (Fig 3C) and multinucleate giant cells also express
CD68 (Fig 3E). In contrast, expression of PI3Kδ is globally absent throughout the granu-
loma (Fig 3D) and also absent in macrophages and multinucleate giant cells (Fig 3F). Posi-
tive controls excluded a technical cause for the absent PI3Kδ staining, and analysis of
further granulomas confirmed the absence of PI3Kδ despite widespread CD68 expression
(S4 Fig).
Therefore, we examined the effect of Mtb infection on macrophage PI3Kδ expression. Mtb
upregulated expression of MMP-1 gene expression at 24h (Fig 3G), but in the same cells signif-
icantly suppressed expression of PIK3CD, the gene endcoding PI3Kδ (Fig 3H). Therefore, the
increase in MMP-1 expression is accompanied by suppression of PI3Kδ in both patients and
primary human macrophages. Stimulation of macrophages with conditioned media from
Mtb-infected cells did not suppress PIK3CD, suggesting that intercellular networks were not
the primary driver of PIK3CD suppression.
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Fig 2. PI3K inhibition has global effects on MMP, cytokine and chemokine secretion by macrophages.
Luminex profiling of MMPs, cytokines, chemokines and growth factors demonstrates that Mtb infection significantly
upregulates a wide range of mediators from macrophages at 72h. Secretion of the majority of mediators was further
augmented when PI3K signalling was globally inhibited. Median values normalised to Mtb-infected samples of an
experiment performed in triplicate are shown, and are representative of an experiment performed on two separate
occasions.
https://doi.org/10.1371/journal.ppat.1006367.g002
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Fig 3. PI3Kδ expression is suppressed in human TB granulomas and infected macrophages. A, B.
Immunohistochemistry analysis of normal human lung tissue demonstrates that alveolar macrophages
express both CD68 and PI3Kδ. C, D. Within human lung TB granulomas, CD68 is widely expressed, but no
PI3Kδ immunoreactivity is observed. E, F. Both epithelioid macrophages and multinucleate giant cells around
TB granulomas express CD68, but neither express PI3Kδ. G. In primary macrophages, Mtb infection
Tuberculosis targets negative regulatory pathways
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AKT and mTORC1 negatively regulate MMP-1 expression in
macrophages
We then studied the signalling pathway directly downstream of PI3Kδ, which includes AKT
and mTORC1. Inhibition of AKT signalling, which is phosphorylated following PI3Kδ activa-
tion, similarly upregulated MMP-1 secretion from macrophages (Fig 4A). Similarly, mTORC1
inhibition with rapamycin augmented Mtb-driven MMP-1 secretion at 72h (Fig 4B), and this
associated with increased MMP-1 gene expression at 24h. Luminex profiling of MMPs and
pro-inflammatory cytokines demonstrated a global effect of upregulation of MMPs and cyto-
kines after mTORC1 inhibition (S5 Fig), as was observed for PI3K inhibition (Fig 2).
We then investigated whether these inhibitory pathways increased MMP-1 via crosstalk
with the pro-inflammatory MAPK pathways, which regulate MMP-1 secretion in macro-
phages [8]. PI3K inhibition did not increase p38 MAPK phosphorylation at either 30 or 240
minutes (Fig 4D and S2 Fig), nor ERK MAPK phosphorylation at these time points (Fig 4E).
We measured cyclo-oxygenase II (COX-II) accumulation, which regulates MMP-1 down-
stream of p38, but PI3K inhibition did not alter COX-II levels within infected macrophages
(Fig 4F). Finally, we investigated whether PI3K linked with NFκB signalling. Mtb increased
the nuclear translocation of p65 in macrophages, but this was not altered by LY294002, sug-
gesting that crosstalk was not occurring at this level (Fig 4G). Therefore, the PI3K pathway
suppresses MMP-1 expression independent of regulating the MAPK, COX-II or NFκB axes.
The MNK pathway also negatively regulates MMP-1 in infected
macrophages
Next, we investigated the MNK pathway, which is downstream of p38 MAPK and regulates
mRNA translation. We hypothesised that MNK inhibition would suppress MMP-1 produc-
tion, but surprisingly MNK inhibition significantly augmented Mtb-driven MMP-1 secretion
(Fig 5A). The increased secretion was secondary to increased MMP-1 gene expression (Fig
5B). To confirm that this is indeed an effect of disabling MNK function, we studied bone mar-
row-derived macrophages from mice in which the genes encoding MNK1 and/or MNK2
(termed Mknk1 and Mknk2) have been disrupted [19]. Mice lack an orthologue of MMP-1
[20], and so we analyzed MMP-3 secretion, which is regulated in a very similar manner to
MMP-1 [21]. Mtb infection increased MMP-3 secretion by murine wild type macrophages,
and MMP-3 secretion was markedly higher in the MNK double knock-out cells, confirming
that the effect of the MNK inhibitor does indeed reflect a negative input from the MNKs to
MMP-3 secretion (Fig 5C). To confirm the efficacy of the MNK-I1 inhibitor [22], we per-
formed Western blotting for phosphorylated eIF4E, a component of the eIF4F translation
complex which is specifically phosphorylated by the MNKs and the only validated in vivo sub-
strate. MNK inhibition suppressed eIF4E phosphorylation as expected (Fig 5D and S6 Fig). To
determine if this effect involved the p90RSK pathway, which is downstream of ERK MAPK,
we specifically inhibited this with BI-D1870 and found no change in MMP-1 secretion (Fig
5E), thereby demonstrating the crosstalk was not via this pathway.
To determine whether the negative regulatory effect of the MNKs was global, as we had
observed for the PI3K/AKT/mTORC1 axis, or more specific, we performed luminex profiling
significantly upregulates MMP-1 expression at 24h, whilst (H) concurrently suppresses PIK3CD mRNA
accumulation. Immunohistochemistry images are representative of six donors with histopathologically
confirmed TB who had lung biopsies as part of their routine clinical care. Scale bars: A, B, E, F: 100μm, C, D:
500 μm. Cellular experiments were performed in triplicate and are representative of at least three donors. P
values are t-test comparisons.
https://doi.org/10.1371/journal.ppat.1006367.g003
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Fig 4. Negative regulation of MMP-1 is via the AKT and mTORC1 pathways, but the PI3K pathway does not cross talk with p38, COX-II or
NFκB signalling. A. Inhibition of AKT significantly increases MMP-1 secretion from macrophages at 72h. B. Inhibition of mTORC1 signalling with
rapamycin similarly augments macrophage MMP-1 secretion at 72h. C. MMP-1 mRNA accumulation is increased in rapamycin-treated cells at
24h. D. Mtb increases p38 phosphorylation in macrophages analysed by western blotting, but PI3K pathway inhibition does not affect this at 30
minutes or 4h. E. PI3K inhibition does not augment constitutive ERK phosphorylation. F. PI3K inhibition has no effect on accumulation of COX-II
Tuberculosis targets negative regulatory pathways
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of MMPs and cytokines. We demonstrated that the MNK effect was relatively specific to
MMP-1, 3 and 10, and only significantly upregulated MCP-1 and EGF amongst the other
inflammatory mediators studied (Fig 6). Blockade of the MNK pathway suppressed secretion
of the majority of TH1 and TH2 cytokines, whereas they had been augmented by PI3K/
mTORC1 pathway inhibition.
PI3K kinase and MNK signalling intersect at eIF4E phosphorylation
We sought to identify a point where the negative regulatory pathways mediated by PI3K and
MNK converge. First, we studied the effect of inhibition of the eIF4F translation initiation
complex, which is required for 5’-cap-dependent protein synthesis. Inhibition of the transla-
tion complex, by disrupting the eIF4E and eIF4G interaction with 4EGI-1 [23], significantly
suppressed MMP-1 secretion (Fig 7A), demonstrating that disrupting the translation factor
complex suppressed synthesis as expected. We therefore then studied eIF4E phosphorylation.
The positive control, insulin, an agonist of the PI3K pathway, increased eIF4E phosphorylation
(Fig 7B, lane one and S6 Fig), whereas inhibition with LY294002, in the absence of any stimuli,
inhibited eIF4E phosphorylation (lane two). MNK inhibition both without and with Mtb
completely suppressed eIF4E phosphorylation as expected. In the context of Mtb stimulation,
specific inhibition of PI3K/PDK1 reduced eIF4E phosphorylation (lane 8), providing evidence
of convergence between MNK and PI3Kδ signalling at this level.
Mtb upregulates a network of microRNAs with targeting sequences in
the 3’UTRs of PIK3CD, MLST8 and MKNK1 mRNAs
Finally, to investigate the mechanism whereby Mtb suppresses PI3Kδ expression, we studied
mRNA stability within macrophages. First, we analyzed total cellular mRNA and demon-
strated that Mtb not only suppressed PIK3CD in macrophages (Fig 8A), but also significantly
suppressed expression of MLST8, a key subunit of mTORC1, and the MNK1 gene, MKNK1
(Fig 8B and 8C). To determine whether this suppression was specific to Mtb, we studied differ-
ent microbial stimuli. Mtb, TLR-2 stimulation and zymosan, a fungal wall component, each
suppressed MKNK1 gene expression in macrophages, while LPS and purified mycolic acid did
not (S7 Fig).
To investigate the underlying mechanism, we performed mRNA pulldown experiments to
characterise newly transcribed gene expression following Mtb infection. 4-Thio uridine was
used to label mRNA and determine the ratio of newly-transcribed mRNA with total mRNA
levels, and thereby demonstrate whether changes were due to altered synthesis or stability.
Newly-transcribed PIK3CD mRNA expression was increased in infected cells, and MLST8 and
MKNK1 were not suppressed (Fig 8D), suggesting the significantly reduced total mRNA levels
were secondary to reduced mRNA stability. This suggested a role for post-transcriptional regu-
lation via microRNAs increasing mRNA degradation, and we therefore analyzed microRNAs
predicted by bioinformatic approaches to target these three mRNAs, using miRBase v21. Mtb
infection upregulated multiple microRNAs, including miR27a, miR125b and miR199, all of
which are predicted suppressors of the PIK3CD, MLST8 and MKNK1 mRNAs (Fig 8E). To
confirm that PIK3CD could be targeted by these miR’s, we generated reporter constructs com-
prising the 3’-UTR fused to Renilla-luciferase. Transfection of HeLa cells with a plasmid
protein in infected macrophages at 24h, analysed by flow cytometry. G. Mtb increases NFκB activation, but no difference is observed after PI3K
inhibition with LY294002. Experiments have been performed on three occasions (A, B, D, E) and two occasions (C, F, G). Mean and standard
deviations are shown and p values are by Student’s t-test.
https://doi.org/10.1371/journal.ppat.1006367.g004
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Fig 5. The MNK pathway is also a negative regulator of MMP-1 expression. A. Chemical inhibition of the MNK pathway by MNK-I1
significantly increases MMP-1 secretion from macrophages at 72h. B. Increased MMP-1 secretion is secondary to increased mRNA
accumulation at 24h. C. Bone marrow derived macrophages from wild type, MNK1-KO, MNK2-KO or double KO mice were uninfected or infected
with Mtb at MOI 1. Supernatants were harvested at 24h, sterile filtered and MMP-3 concentration analyzed by Luminex array. MMP-3 secretion
was significantly elevated in the MNK double KO cells. Representative experiment of two each performed in triplicate. D. MNK inhibition
Tuberculosis targets negative regulatory pathways
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expressing miR7, which is predicted to target PIK3CD, suppressed luminescence, whilst a site-
directed mutant within the predicted binding region did not, confirming that miR-7 may
directly bind to PIK3CD to reduce mRNA or protein levels (Fig 8F). Therefore, the reduced
stability of mRNA is most likely secondary to Mtb-induced upregulation of microRNAs that
target these transcripts.
Discussion
Mtb must cause pathology to be transmitted to new hosts, and patients with pulmonary cavi-
ties are the most infectious [3, 24]. Whilst the mechanisms whereby Mtb evades the host
immune responses have been extensively investigated [25], relatively little is known about how
Mtb engages the immune response to drive tissue destruction, cavitation and transmission
[26]. Immune evasion will only lead to latent TB without onward transmission, and so the ini-
tiation of immunopathology is an essential event in the Mtb life cycle [27]. We have identified
negative regulatory pathways that limit pathogenic MMP-1 secretion by primary human mac-
rophages and observed the absence of PI3Kδ in TB granulomas in patients. We demonstrated
that Mtb disables the PI3Kδ/AKT/mTORC1 and MNK regulatory pathways to drive a pro-tis-
sue destructive phenotype, thereby uncovering a previously unidentified role of the MNK
pathway as inhibitor of MMP-1 expression (Fig 9).
Direct macrophage infection by Mtb was required in vitro for suppression of PIK3CD,
while widespread suppression was observed in lung granulomas, where mycobacteria are rela-
tively sparse [28]. This suggests that either accumulation of Mtb antigens within granulomas
may suppress PIK3CD expression in non-infected cells, or that a more complex regulation
occurs during the long host-pathogen interaction in patients relative to the short-term cellular
experiments possible in vitro. Since intercellular networks can upregulate MMP-1 secretion
without suppressing PIK3CD, we propose that the down-regulation of the negative regulatory
pathways serves to further augment a tissue-destructive proteolytic pathway caused by both
direct infection and intercellular signalling to facilitate cavitation and transmission. Inter-
feron-γ, a key cytokine in the host immune response to TB, also targets mTORC1 and MNK
signalling [29], demonstrating the complex interplay between pathways and consistent with
the emerging hypothesis that either an insufficient or excessive host immune response may be
deleterious [30].
Pathology in TB results from dysregulation of inflammation [31] and MMPs are emerging
as key pathological mediators [4]. p38 and ERK MAPKs are positive regulators of MMP
expression, and p38 is phosphorylated in patients [8], while PI3K is a negative regulator in
stromal cells [32]. We demonstrate in primary human macrophages that PI3K, AKT,
mTORC1 and MNKs are all negative regulatory pathways, and are suppressed by Mtb infec-
tion. Consistent with our findings, PI3K limits IL-12 secretion and TLR signalling in LPS-
stimulated dendritic cells [10, 11], suggesting that these early signalling events that occur
immediately after receptor activation having a broad regulatory effect to diverse stimuli and
lead to increased cytokine secretion. A similar role for PI3Kγ in controlling a macrophage
switch between immune stimulation and suppression in cancer has very recently been
described in murine macrophages [33] In that study, the signalling was via NFκB, but we were
unable to demonstrate cross-talk at this level. Similar to our results in primary macrophages,
in human PBMCs, Mtb has been shown to phosphorylate AKT and mTORC1, and rapamycin
suppresses phosphorylation of eIF4E at 180 mins. E. Inhibition of the p90RSK pathway does not significantly change MMP-1 secretion at 72h. A,
B: data represent experiments performed in triplicate on a minimum of two occasions, D: 3 separate donors, E: two donors in triplicate. Mean and
standard deviation are shown and p values are Student’s t-test.
https://doi.org/10.1371/journal.ppat.1006367.g005
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Fig 6. Negative regulation of MMPs by MNK is more specific than PI3K/AKT/mTORC1 signalling. Global
analysis of MMP, cytokine, chemokine and growth factors secretion from macrophages at 72h by Luminex array
demonstrates that MNK inhibition augments MMP-1, MMP-3 and MMP-10 secretion significantly, but conversely
suppresses TH1, TH2 and chemokine secretion. Median values normalised to Mtb values of an experiment performed
in triplicate are shown, and are representative of an experiment performed on two occasions.
https://doi.org/10.1371/journal.ppat.1006367.g006
Tuberculosis targets negative regulatory pathways
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006367 June 1, 2017 12 / 25
increases secretion of TNF-α, IL-1β and IL-6 [34]. The skewing of intracellular signalling in
macrophages by Mtb may negate the effect of TH2 cytokines, such as IL-4 and IL-10, and regu-
latory T cells that are thought to limit immune-mediated tissue destruction in TB [30, 35].
We have identified a novel role for MNK signalling in limiting tissue-destructive MMPs
and found that this was relatively specific, whereas the effect of PI3K/AKT/mTORC signalling
on inflammatory mediators was much more widespread. The effect of MNK inhibition was
striking and more pronounced that phenotypes observed with stimuli other than Mtb. MNK is
downstream of p38 and ERK MAPK signalling [13], and is considered to regulates protein syn-
thesis [36]. Therefore, we had predicted that MNK inhibition would suppress MMP-1. MMP-
1 downregulation was observed when we directly suppressed eIF4F complex formation,
Fig 7. The PI3K and MNK pathways converge at the level of eIF4E phosphorylation. A. Inhibition of eIF4F complex
formation significantly suppresses MMP-1 secretion from Mtb-infected macrophages at 72h. B. Insulin, a PI3K pathway
activator, increases macrophage eIF4E phosphorylation, while LY294002 abrogates phosphorylation. Mtb infection does
not change basal eIF4E phosphorylation levels, but either MNK or PI3K/PD-1 inhibition suppresses eIF4E phosphorylation
at 90 mins. A: representative data from an experiment performed in 2 donors in triplicate, B: performed on three occasions
in different donors. Mean and standard deviation shown and p values are by Student’s t-test.
https://doi.org/10.1371/journal.ppat.1006367.g007
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Fig 8. Mtb infection reduces stability of negative regulatory pathway genes and increases microRNA accumulation. A, B, C.
Mtb infection of macrophages suppresses total PIK3CD, MLST8 and MKNK1 mRNA levels at 24h after infection. D. In contrast,
synthesis of newly transcribed mRNA for each gene is increased at 24h. E. Mtb infection of macrophages upregulates multiple
microRNAs that are predicted to target the negative regulatory pathways analyzed at 48h. F. miR-7 targeting the 3’UTR of PIK3CD
suppresses luciferase activity. Hela cells were co-transfected with a miR-7 expressing vector (miR-7) and a Renilla Luciferase
construct harbouring either a PIK3CD-3’UTR fragment containing the miR-7-5p binding site (bp 268–275) (Wild Type, WT), the same
Tuberculosis targets negative regulatory pathways
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whereas MNK inhibition increased MMP secretion while suppressing cytokines. We con-
firmed that the MNK inhibitor, MNK-I1, was acting specifically by blocking MNK function by
studying MNK-deficient mouse cells. The majority of cytokines were suppressed by MNK
inhibition, and so the overall effect may be to increase destruction of the extracellular matrix
in the absence of an increased host inflammatory response that might favour bacterial killing.
We demonstrated that other, but not all, infectious stimuli suppress MKNK gene expression,
suggesting that this response may occur to a range of pathogen-derived molecules, and is
usurped by Mtb to increase matrix destruction. This phenomenon requires further systematic
dissection for full characterisation. MNK is thought to increase translation [12, 37], and there-
fore the phenotype of increased MMP-1 after MNK inhibition may be due to reduced
PIK3CD-3’UTR construct with mutated miR-7-5p binding site (bp 268–275) (Mutant), or empty construct (Control). RLA: Relative
Luciferase Activity. Mean and standard deviation are shown, p values are by Student’s t-test and data are representative of
experiments performed on at least two occasions in triplicate. F. Combined results from 4 independent experiments.
https://doi.org/10.1371/journal.ppat.1006367.g008
Fig 9. Mtb inhibits negative regulatory pathways in macrophages. Mtb upregulates MMP-1 via the MAPK pathways, whilst concurrently inducing
microRNAs that target the negative regulatory pathways that limit MMP-1 expression, leading to excessive protease production and tissue destruction.
https://doi.org/10.1371/journal.ppat.1006367.g009
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inhibitory transcription factor production, as has been demonstrated for type I interferons in
viral infection [38]. Therefore, our findings suggest that modulating MNK will exert a more
nuanced effect within the cellular machinery than purely inhibiting protein synthesis.
Our RNA analysis suggested Mtb infection reduced stability of mRNAs encoding negative
regulatory proteins, and we identified Mtb-driven increases in microRNAs that target the sig-
nalling cascade at multiple levels. We demonstrated that miR-7 binds to the 3’UTR of PIK3CD,
as predicted bioinformatically. miRNAs are responsible for fine tuning transcription and usu-
ally multiple miRNAs combine to reduce the levels of a given mRNA with an additive effect
[15]. We identified that multiple miRNAs predicted to target each negative regulatory pathway
[39] were increased in Mtb infection, suggesting an overall effect skewing the transcriptional
response to a matrix-degradative phenotype. However, systematic characterisation of each
miR interaction with each regulatory pathway will be required to fully confirm this hypothesis.
We demonstrated that intercellular networks could augment MMP-1 secretion, but did not
suppress PIK3CD gene expression, indicating that dual regulatory effects are likely to be oper-
ant in vivo, with infected cells being particularly predisposed to excessive protease secretion.
Cytokine networks may augment MMP secretion by bystander cells in the absence of PIK3CD
suppression. Since mice do not express MMP-1 [40], further dissection of this regulatory path-
way will likely require gene editing in advanced human cell culture model systems.
In summary, we identify a novel strategy employed by Mtb to drive immunopathology by
disrupting negative regulatory pathways, both in primary macrophages and in patients. We
demonstrate a previously unrecognised role of the MNK pathway as a negative regulator of
MMP secretion. Inhibitors of PI3Kδ are already in clinical use, and other drugs are in develop-
ment, and therefore it is possible that they may increase the risk of active TB in the same way
as anti-TNF-α agents [41]. Furthermore, novel host-directed therapies that target intracellular
signalling pathways to enhance Mtb killing [42] must not inadvertently suppress the negative
regulatory pathways and thereby augment immunopathology.
Materials and methods
Ethics statement
Samples used in this study were sourced from the Southampton Research Biorepository, Uni-
versity Hospital Southampton NHS Foundation Trust and University of Southampton, Mail-
point 218, Tremona Road, Southampton, SO16 6YD. Lung biopsy tissue was taken as part
of routine clinical care and tissue blocks excess to diagnostic testing were analyzed in this
study. The project was approved by the Institutional Review Board (Reference 12/NW/0794
SRB04_14). The ethics committee approved the analysis of this tissue without individual
informed consent since it was surplus archived tissue taken as part of routine care. For analysis
of blood from healthy donors, this work was approved by the National Research Ethics Service
committee South Central—Southampton A (ref 13 SC 0043) and all donors gave written
informed consent.
Chemicals and reagents
Standard laboratory reagents were from Sigma Aldrich. Chemical inhibitors were pan-PI3K:
LY294002; PI3Kδ: IC87114; mTORC1: Rapamycin (Merck Millipore); AKT: MK-2206 (Insight
Biotechnology); PI3K/PDK-1: NVP-BAG956; eIF4E/eIF4G interaction: 4EGI-1 (Merck Chem-
icals); P90RSK: BI-D1870 (Selleckchem). MNK-I1 was kindly synthesised by Professor Jiang
Tao and her colleagues at the Ocean University of China, Qingdao, China. Infectious stimuli
were: Zymosan (Sigma, 100μg/ml), LPS (Sigma, 1μg/ml), TLR-2 agonist Pam Cys-Ser-(Lys)
[Pam3Cys] (MerkMillipore, 100ng/ml), Mycolic acid (Sigma, 10 μg/ml).
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PBMC cell isolation from human blood
PBMCs were isolated from single donor leukocyte cones (National Health Service Blood and
Transfusion, Southampton, UK) or fresh blood from healthy donors by density gradient cen-
trifugation over Ficoll-Paque (GE Healthcare Life Sciences). Monocytes were plated at
250,000cm2, adhered for 1 hour and then washed 3 times to remove non-adherent cells.
Monocytes were matured to macrophages for 4 days in complete RPMI with 10% human
serum with 100ng M-CSF, then rested for 1 day in complete medium without growth factors,
and then the experiment was started (Day 0).
M. tuberculosis culture
M. tuberculosis H37Rv (Mtb) was cultured in Middlebrook 7H9 medium (supplemented with
10% ADC, 0.2% glycerol and 0.02% Tween 80) (BD Biosciences, Oxford) with agitation. Cul-
tures at 1x 108 CFU/ml Mtb (OD = 0.6) was used for all experiments.
Macrophage infection
Macrophages were infected with Mtb at MOI of 1. Cells were washed one hour after infection
to remove non-phagocytized Mtb. Experimental duration was between hours for analysis of
protein phosphorylation and 3 days for secretion. For experiments involving chemical inhibi-
tors, cells were pre-incubated with inhibitor for 2h prior to infection with Mtb.
MMP-1 ELISA and Luminex array
MMP-1 concentrations were analyzed by ELISA assay according to manufacturer’s protocol
(R & D Systems). For multianalyte profiling, MMP and cytokine concentrations in cell culture
supernatants harvested at 72h were analyzed on a Bioplex 200 platform (Bio-Rad, Hemel
Hempstead, U.K.). MMP concentrations were analyzed by the MMP Fluorokine multianalyte
profiling (R&D Systems, Abingdon, U.K) and cytokine concentrations were measured using
the Cytokine Human 30-Plex Panel for the Luminex platform (Invitrogen, Paisley, UK)
according to manufacturers’ protocol.
Phosphorylation Western blotting
MDMs were infected with Mtb and lysed with 200μl SDS sample buffer (62.5mM Tris pH 6.8,
2% SDS, 10% glycerol, 50mM DTT, 0.01% Bromophenol blue) at defined time points. Samples
were filtered through 0.2μM Anopore filter and frozen at -80˚C. 20μl aliquots were heat dena-
tured and run on a 10% acrylamide gel at 200V (Running buffer 25mM Tris base, 192mM
glycine, 0.1% SDS) for 3h. Gels were electro-transferred to a nitrocellulose membrane (Amer-
sham) and blocked for 1h with 5% milk protein / 0.1% Tween-20. The membrane was incu-
bated with primary antibody (AKT or phospho-AKT Ser 473, p38 or phospho-p38, ERK or
phospho-ERK, Cell Signalling Technology; eIF4E and phosphor eIF4E, Merck Millipore) in
5% BSA / 0.1% Tween at 4˚C overnight. Blots were then washed three times and incubated
with HRP-linked anti-rabbit secondary antibody (Cell Signalling Technology, 1/2000 dilution
in 5% milk protein / 0.1% Tween) for 1h. Luminescence was detected with the ECL system
(Amersham) according to manufacturer’s protocol. Immunoblotting for total p38, ERK or
AKT confirmed equal loading between samples.
Quantitative RT-PCR
MDMs were lysed with TRI-reagent (Sigma-Aldrich), isolated with chloroform phase separa-
tion and precipitated with isopropanol. RNA was quantified by NanoDrop and retro-
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transcribed to complementary DNA by the High Capacity cDNA Reverse Transcription kit
(Life Technologies, Paisley, UK). cDNAs obtained were then used for micro RNA and gene
expression quantification assays by RT-qPCR for MMP-1 (Hs00899658_m1), PIK3CD
(Hs00192399_m1), MLST8 (Hs00909882_g1), MKNK1 (Hs00374375_m1) and GAPDH
(Hs02758991_g1) following manufacturer’s instruction (Applied Biosystems, USA). For
microRNA’s, miRNA primers were from TaqMan OpenArray Human MicroRNA Plate
(ThermoFisher Scientific, UK), with the following catalogue numbers: miR-7 TM000268,
miR-27a TM000408, miR-30a TM000417, miR-221 RT524, miR-125b TM449, miR-199
TM498, miR-22 TM000398, miR-135a TM000480. Taqman Universal master mix and primers
specific for the gene of study and GAPDH as house-keeping gene were used. Each RT-qPCR
experiment was performed in duplicates and results were analyzed using SDS version 2.3
sequence detection systems (Applied Biosystems, USA). Comparative CT method was
employed to analyze all RT-qPCR data.
Immunohistochemistry
Paraffin-embedded lung tissues were mounted at 4μm thin onto APS coated glass slides and
dried. Sections were dewaxed and 30% hydrogen peroxide used to block endogenous peroxi-
dase. Sections were washed three times in TBS buffer and heat induced-epitope retrieval
employed by boiling the slides in 1mM EDTA (pH 8.0) in distilled water for 25 minutes. Slides
were incubated in Avidin solution for 20 minutes, followed by 3 washes. This was followed by
incubation in biotin solution for 20 minutes followed by another wash step. The slide was
blocked with Dulbecco’s Modified Eagle Medium (DMEM) containing with 10% FCS and 2%
BSA for 20 minutes. Slides were incubated at 4˚C overnight in appropriately diluted primary
antibody; 1:1000 dilution of anti-PIK3δ (LifeSpan BioScience,Inc) or ready–to-use monoclonal
mouse CD68 antibody, clone PG-M1 (Dako, IR613). Sections were washed and incubated in
1:400 of biotinylated rabbit anti mouse (Dako) secondary antibody for 30 minutes. After a sec-
ond wash, sections were incubated for 30 minutes in streptavidin biotin-peroxidase complexes
(Elite vectastain ABC kit, Vector laboratories). Sections were washed and incubated in DAB
(2-component DAB pack, BioGenex) substrate for 5 minutes. Counter staining was performed
in Mayer’s haematoxylin for 20 seconds. Dehydration of slides was performed at 1 minute in
graded alcohols and mounted in pertex. Images were captured on Olympus CC12 (dotSlide)
microscope.
COX-2 flow cytometry analysis
MDMs were infected with Mtb, in the presence or absence of inhibitors, as above. Cells were
fixed in 4% paraformaldehyde for 30 minutes at room temperature then lifted mechanically.
Anti-COX II FITC labelled intracellular staining was performed according to manufacturer’s
instructions (Cayman Chemicals). Briefly, cells were washed and permeabilized with 0.5%
BSA, 0.1% Na azide, 0.1% Saponin solution. After a further wash step, cells were incubated
with primary antibody (1/10 dilution) or IgG control (1/200 dilution, mouse IgG1 FITC, Sero-
tec) for 30 minutes at room temperature in the dark. Cells were re-suspended in PBS and ana-
lyzed by flow cytometry on a Becton Dickinson FACS Calibur.
Nuclear and cytoplasmic extract preparation
MDMs were infected with Mtb, in the presence or absence of inhibitors and cytoplasmic and
nuclear extracts were prepared using the NE-PER kit (Pierce Biotechnology, Perbio) according
manufacturer’s instructions. Briefly, cells were mechanically lifted into ice cold PBS, microcen-
trifuged and the supernatants removed leaving the pellet as dry as possible. Halt Protease
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Inhibitor Cocktail (Pierce, Perbio) was added to the stock solutions and the appropriate vol-
ume of ice cold CERI was added to the pellet. After re-suspension by vortexing, samples were
incubated on ice for 10 minutes and CERII solution was added. Samples were vortexed and
after centrifugation at 4˚C for 5 minutes the supernatant containing the cytoplasmic extract
was immediately collected, and filtered through a 0.2μM Durapore filter (Millipore). Ice cold
NER was added to the remaining pellet containing nuclei, and vortexed for 15 seconds every
10 minutes for a total of 40 minutes on ice. After centrifugation the supernatant was harvested,
filtered through a 0.2μM Durapore filter (Millipore) and all extracts stored at -80˚C.
TransAm ELISAs
Transcription factor activation in nuclear extracts was determined by TransAm ELISA based
assay kits (Active Motif, UK) according to manufacturer’s instructions. Total protein concen-
tration was measured by Bradford assay (Biorad) and 5μg of nuclear extract was used for each
sample. The lower level of sensitivity was <0.5μg of nuclear or whole cell extract.
Bone Marrow Derived Macrophages from MNK deficient mice and MMP-
3 luminex
Bone Marrow Derived Macrophages (BMDM) from MNK1, MNK2 or MNK Double mutant
mice were acquired from South Australian Health and Medical Research Institute, Australia.
After defrosting, macrophages were cultured in complete macrophage medium, which is com-
posed of L929 cell conditioned medium, 20% FCS and DMEM with 10ng/ml of M-CSF over-
night, and were infected with Mtb H37Rv at MOI of 1 for 24 h. Supernatants were harvested
for analysis and sterile filtered. Mouse MMP-3 Fluorokine beads (R&D Systems) were used to
measure concentrations of MMP-3 in supernatant from BMDM on the Luminex 200 platform
(Bio-Rad, Hertfordshire, UK). The lower limit of detection of the assay was 2 pg/ml. Assays
were performed per manufacturer’s instructions.
Thio uridine labelling of RNA and pulldown analysis
To analyze newly synthesised mRNA, 100μM of 4-Thio uridine was added to infected macro-
phages for at least 24h, lysed in Tri-reagent and total RNA extracted. 1mg/ml of EZ-Link
biotin-HPDP (Pierce, Thermo Fisher Scientific UK Ltd.) solution was prepared in Dimethyl-
formamide (DMF). 1μl of 1mg/ml of EZ-Link biotin-HPDP solution was used per μg of total
4-TU labelled RNA. Master mix was prepared from 1M Tris (pH 7.4) and 0.5M EDTA to a
final concentration of 10mM Tris and 1mM EDTA, in RNase free water. Isopropanol at vol-
ume equal to the final reaction volume and 5M NaCl (at 1/10th final reaction volume) were
added to the biotinylated 4-TU labelled RNA. The mixture was vortexed and incubated at
room temperature for 5 minutes before being centrifuged at 13000rpm for 20 minutes. The
RNA pellet was washed in 250μl 75% Ethanol, followed by 10 minutes centrifugation. The pel-
let was allowed to air-dry until semi-transparent, and RNA was re-suspended in 20–50μl of
RNase free water. The re-suspended RNA was purified immediately or stored at -80˚C for
future pulldown analysis.
To isolate and purify the 4-TU labelled RNA, Magnetic Porous Glass (MPG) streptavidin
beads (Pure Biotech LLC) was used to bind and pull down the biotinylated 4-TU labelled
RNA. The beads were incubated with tRNA (1μg per 5μl of beads) and rotated at room tem-
perature for 20 minutes. Tubes were placed in magnetic stand beads for 1 minute. This was fol-
lowed by three washes in 300μl of MPG buffer (1M NaCl, 10mM EDTA, 100mM Tris-HCL at
pH 7.4 in RNase free water). Beads were re-suspended in MPG buffer equal to the original vol-
ume of beads. Volume of RNA and beads were adjusted to be equal, to allow 1:1 combination
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ratio. The biotinylated 4-TU RNA was added to the beads and incubated at room temperature
with rotation for 1 h. Beads were collected in a magnetic stand for 1 minute. The supernatant
was collected and kept as unbound, non-4TU RNA. Beads were washed two times in 250μl of
room temperature MPG buffer, one wash in 65˚C MPG buffer, and a final wash in 50μl MPG
buffer. The supernatant from the last wash was kept as ‘wash RNA’ to check for flow through
RNA.
To elute the bead-bound, 4-TU labelled RNA, freshly prepared 5% β-mercaptoethanol was
added at volume equal to original bead volume and incubated at room temperature with rota-
tion for 20 minutes. The tubes were centrifuged, and beads collected in a magnetic stand for 1
minute. The supernatant was kept as bound, 4-TU labelled RNA. RNA was precipitated as
described above by adding 5M NaCl at 1/10th the RNA volume, isopropanol at the same vol-
ume as the RNA, and 1μg glycogen. The mixture was incubated at room temperature for 5
minutes and centrifuged for 20 minutes. The RNA pellet was washed in 250μl 75% Ethanol fol-
lowed by 10 minutes centrifugation. The pellet was allowed to air-dry until semi-transparent,
and RNA was re-suspended in 20–50μl of RNase free water. The re-suspended RNA was
placed in the magnetic stand to collect any residual beads. The supernatant was collected in
newly labelled nuclease free tubes as purified, newly synthesised RNA samples.
Purified 4-TU labelled RNA was treated with rDNase (DNA-free Kit, Life Technologies) to
remove potential genomic DNA contamination. SuperScript III Reverse Transcriptase (Invi-
trogen), Oligo (dt)12–18 primer (Invitrogen) and random hexamer (Component of high
capacity cDNA kit, Life Technologies Ltd.) were used to retro transcribe 5μg of the pulled
down RNA to cDNA in a 20μl reaction volume according to the manufacturer’s protocol. The
mixture was heated at 65˚C for 5 minutes, after which tubes were incubated on ice for a further
1 minute. 4μl, 1μl and 2μl of 5x first strand buffer, 0.1MDTT, SuperScript III Reverse Tran-
scriptase respectively (all from Invitrogen) and 1μl of RNaseOUT (Invitrogen) were added.
Reverse transcription was performed by incubating tubes at 25˚C for 5 minutes, 55˚C for 40
minutes and at 70˚C for 15 minutes. The cDNA was stored in -20˚C for RT-qPCR amplifica-
tion as above.
Micro-reverse transcription (micro-RT)
To quantify expression of the micro RNAs of interest, cellular RNA was converted to cDNA as
above. For micro-RT, 10ng/μl of RNA concentration (diluted using RNase-free water) and
stem-loop primers that are specific for each of the microRNA of interest were used. RT-qPCR
was performed using TaqMan Gene Expression Assays (Thermo Fisher Scientific).
Vector construction and transfection experiments
Regions of interest were first amplified from genomic DNA by PCR using GoTaq G2 Polymer-
ase (Promega) with standard additions to the PCR mastermix. The genomic region encom-
passing miR-7-3 was amplified using the following forward; CTCGAGGGGTCTCAGACATG
GGGCAGAGGG and reverse; AAGCTTCCACTGGCCAGCCCATTGAAGGCG primers
with XHOI and HINDIII restriction sites. For the PIK3CD-3’UTR, forward; TCTAGACAAG
CACATTGGTCCTAAAGGGGC and reverse; GCGGCCGCAAGGCATCCTGTCGGACAG
TAGGC primers with XBAI & NOTI sites were used to amplify a 362nt fragment of the
PIK3CD-3’UTR containing the 8mer miR-7-5p binding site. Each product was cloned sepa-
rately into pCR 2.1-TOPO (Invitrogen) and amplified in plasmid DNA using the TOPO TA
cloning kit method (Invitrogen) and chemically competent E. Coli. The amplified sequences of
interest were removed from pCR 2.1 TOPO and inserted into pCDNA 3.1 (miR-7) or pRLTK
(PIK3CD-3’UTR) using XHOI/HINDIII or XBAI/NOTI restriction sites, respectively.
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To assess the specificity of the miR-7-5p putative binding site in the PIK3CD-3’UTR frag-
ment, a 4nt substitution removing sequence complementarity to the miR-7-5p seed sequence
was performed by QuickChange Site Directed Mutagenesis (Stratagene), using a previously
outlined method [43]. Primer sequences for the PIK3CD-3’UTR mutant were forward; GGAT
TGTCACCCCAAGGATCCCAGCTGGTGGATCTG and reverse; CAGATCCACCAGCTGG
GATCCTTGGGGTGACAATCC.
To determine direct targeting of PIK3CD by miR-7, the pCDNA 3.1_miR-7 construct was
co-transfected in to HeLa cells with either pRL-TK_PIK3CD-3’UTR or pRL-TK_PIK3CD-
3’UTR_MUTANT vectors, using SuperFect (Qiagen) and manufacturers recommendations.
Empty pRL-TK vector and a pCDNA 3.1 construct containing a non-related insert (PU.1
3’UTR) were used as control vectors to elucidate miR-7 activity against PIK3CD-3’UTR. The
pGL3 Luciferase reporter (Promega) was used as a normalising vector to assess transfection
efficiency. Luminometry was performed using the Dual-Glo Luciferase assay system (Pro-
mega) following manufacturer’s instructions. Experimental conditions performed in duplicate
were averaged, and 4 independent experiments were performed.
Statistical analysis
Analysis was performed using Graphpad Prism v6.0. Multiple intervention experiments were
compared with the One Way ANOVA followed by Tukey’s multiple comparison. A p value of
<0.05 was taken as statistically significant. For secretion data, experiments were performed in
triplicate on a minimum of 2 occasions, while for RNA analysis representative data from at
least 3 independent experiments is shown.
Accession numbers
Uniprot accession numbers for the principal proteins discussed are; MMP-1 P03956, PI3Kδ
O00329, mTORC1 P42345, MNK Q9BUB5
Supporting information
S1 Fig. Expression of PIK3CD is not suppressed by PI3K pathway inhibitors. Primary mac-
rophages were incubated with inhibitors for 24h and PIK3CD expression analyzed by RT-
qPCR. PIK3CD expression in fact was increased after 24h of inhibitors.  p < 0.05,  p< 0.01.
(TIF)
S2 Fig. Densitometry of AKT, p38 and ERK western blots. Digital image analysis of western
blots was performed using Image J and normalised to loading controls. A, B, C: AKT. D, E:
p38. F, G: ERK.
(TIF)
S3 Fig. Intercellular networks augment macrophage MMP-1 production. Conditioned
media was prepared from uninfected or Mtb-infected macrophages that had been harvested at
72h after infection and sterile filtered. Macrophages were stimulated with this conditioned
media at 1 in 5 dilution and incubated for 72h before analysis. MMP-1 concentrations in cell
culture supernatant was analyzed by Luminex. Conditioned media from infected macrophages
significantly increased MMP-1 secretion compared to media from uninfected macrophages,
demonstrating intercellular networks augment MMP-1 secretion. Representative data of an
experiment performed in triplicate on 2 occasions is shown.
(TIF)
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S4 Fig. CD68 is widely expressed in TB granulomas while PI3Kδ is absent. A. CD68 immu-
nohistochemistry of lung biopsy at low power (x4). B. PI3Kδ expression is absent within the
granuloma (x4). C. Tonsil positive control for CD68. D. Kidney positive control for PI3Kδ.
E. Tonsil, secondary antibody alone. F. Kidney, secondary antibody alone.
(TIF)
S5 Fig. mTORC1 inhibition has global effects on MMP, cytokine and chemokine secretion
by macrophages. Luminex profiling of MMPs, cytokines, chemokines and growth factors
demonstrates the majority of mediators upregulated by Mtb were further augmented when
mTORC1 signalling was inhibited by rapamycin. Median values normalised to Mtb-infected
samples of an experiment performed in triplicate are shown, and are representative of an
experiment performed on two occasions.
(TIF)
S6 Fig. Densitometry of eIF4E western blots. Digital images of western blots was performed
using Image J and normalised to loading controls. A: eIF4E / p-eIF4E. B: eIF4E / β-actin
(TIF)
S7 Fig. Mtb, fungal stimuli and TLR-2 stimulation suppressMKNK1 gene expression but
other infectious stimuli do not. Primary human macrophages were unstimulated or stimu-
lated with Mtb (MOI 1), zymosan (100μg/ml), LPS (1μg/ml), TLR-2 agonist Pam3Cys (100ng/
ml) or mycolic acid (10μg/ml). Cells were lysed at 48h with Trizol and MKNK1 gene expres-
sion analyzed by RT-qPCR. Mtb, zymosan and TLR-2 stimulation suppressed MKNK1 expres-
sion, while LPS and mycolic acids did not.
(TIF)
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